BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 2048490)

  • 21. Clean intermittent catheterization in congenital neurogenic bladder.
    Opsomer RJ; Aad AA; Van Cangh PJ; Wese FX
    Acta Urol Belg; 1989; 57(2):537-43. PubMed ID: 2763930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized Clinical Trial Using Sterile Single Use and Reused Polyvinylchloride Catheters for Intermittent Catheterization with a Clean Technique in Spina Bifida Cases: Short-Term Urinary Tract Infection Outcomes.
    Madero-Morales PA; Robles-Torres JI; Vizcarra-Mata G; Guillén-Lozoya AH; Mendoza-Olazarán S; Garza-González E; Gutiérrez-González A
    J Urol; 2019 Jul; 202(1):153-158. PubMed ID: 30916625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 14 years of experience with the artificial urinary sphincter in children and adolescents without spina bifida.
    Ruiz E; Puigdevall J; Moldes J; Lobos P; Boer M; Ithurralde J; Escalante J; de Badiola F
    J Urol; 2006 Oct; 176(4 Pt 2):1821-5. PubMed ID: 16945659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and follow-up of vesico-ureteral reflux in patients with neuropathic bladder.
    Di Rovasenda E; Podestà E; Scarsi P; Sangiorgio L; Ferretti S; Buffa P
    Eur J Pediatr Surg; 1992 Jun; 2(3):152-3. PubMed ID: 1498105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uroneurological assessment of spina bifida cystica and occulta.
    Sakakibara R; Hattori T; Uchiyama T; Kamura K; Yamanishi T
    Neurourol Urodyn; 2003; 22(4):328-34. PubMed ID: 12808708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization.
    Seki N; Masuda K; Kinukawa N; Senoh K; Naito S
    Int J Urol; 2004 Nov; 11(11):973-7. PubMed ID: 15509200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of intermittent catheterization in neurogenic bladder in children and adolescents. 165 cases from 1976 to 1986].
    Mollard P; Basset T; Gounot E; Sol Hernandez A; Viguier JL
    Chir Pediatr; 1987; 28(6):269-75. PubMed ID: 3447765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive factors of hydronephrosis in patients with spina bifida: reports from China.
    Ma Y; Li B; Wang L; Han X
    Int Urol Nephrol; 2013 Jun; 45(3):687-93. PubMed ID: 23483305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The spina bifida child with special reference to urologic disease].
    Seiferth J
    Fortschr Med; 1977 Jan; 95(2):103-6. PubMed ID: 13031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of vesicoureteral reflux in children with neurogenic bladders.
    Kass EJ; Koff SA
    Z Kinderchir; 1981 Dec; 34(4):379-83. PubMed ID: 7331545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clean intermittent catheterization in the management of the neurogenic bladder in children.
    Cass AS; Luxenberg M; Gleich P; Johnson CF; Hagen S
    J Urol; 1984 Sep; 132(3):526-8. PubMed ID: 6471189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting renal scar development in children with spina bifida.
    Ozel SK; Dokumcu Z; Akyildiz C; Avanoglu A; Ulman I
    Urol Int; 2007; 79(2):133-6. PubMed ID: 17851282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization.
    Zegers B; Uiterwaal C; Kimpen J; van Gool J; de Jong T; Winkler-Seinstra P; Houterman S; Verpoorten C; de Jong-de Vos van Steenwijk C
    J Urol; 2011 Dec; 186(6):2365-70. PubMed ID: 22019031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation ileocystoplasty in patients with neurogenic bladder due to spinal cord injury or spina bifida.
    Nomura S; Ishido T; Tanaka K; Komiya A
    Spinal Cord; 2002 Jan; 40(1):30-3. PubMed ID: 11821967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of myelomeningocele.
    Kaplan WE
    Urol Clin North Am; 1985 Feb; 12(1):93-101. PubMed ID: 3883627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical investigation of clean intermittent catheterization].
    Fujimoto Y; Ueno K; Yamada S; Isogai K; Komeda H; Ban Y
    Hinyokika Kiyo; 1994 Apr; 40(4):309-13. PubMed ID: 8191969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clean intermittent catheterization in neurogenic bladder patients with vesicoureteral reflux].
    Takechi S; Nishio S; Yokoyama M; Iwata H; Takeuchi M
    Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1520-4. PubMed ID: 7474600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood.
    Mourtzinos A; Stoffel JT
    Urol Clin North Am; 2010 Nov; 37(4):527-35. PubMed ID: 20955904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intractable high-pressure bladder in female infants with spina bifida: clinical characteristics and use of vesicostomy.
    Lee MW; Greenfield SP
    Urology; 2005 Mar; 65(3):568-71. PubMed ID: 15780378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.